Stroke in adults with congenital heart disease incidence, cumulative risk, and predictors

Circulation

Volumn 132, Issue 25, 2015, Pages 2385-2394

  Lanz, Jonas ^a   Brophy, James M ^c   Therrien, Judith ^a   Kaouache, Mohammed ^a   Guo, Liming ^a   Marelli, Ariane J ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Congenital; Epidemiology; Heart defects; Incidence; Risk factors; Stroke

Indexed keywords

ADOLESCENT; ADULT; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; HEART DEFECTS, CONGENITAL; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84953347850     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.011241     Document Type: Article

References (45)

1. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle W.T., Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008; 153:807-813. doi:10.1016/j.jpeds.2008.05.059.
2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007; 115:163-172. doi:10.1161/CIRCULATIONAHA.106.627224.
3. Khairy P, Ionescu-Ittu R, Mackie A.S., Abrahamowicz M., Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010; 56:1149-1157. doi:10.1016/j.jacc.2010.03.085.
4. Marelli A, Beauchesne L, Mital S., Therrien J, Silversides CK. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: introduction. Can J Cardiol. 2010; 26:e65-e69.
5. Go AS, Mozaffarian D, Roger V.L., Benjamin EJ, Berry JD, Borden WB, Bravata D.M., Dai S., Ford ES, Fox CS, Franco S, Fullerton H.J., Gillespie C., Hailpern SM, Heit JA, Howard VJ, Huffman M.D., Kissela BM, Kittner SJ, Lackland DT, Lichtman J.H., Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar D.B., McGuire DK, Mohler ER, Moy CS, Mussolino M.E., Nichol G., Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013; 127:e6-e245. doi:10.1161/CIR.0b013e31828124ad.
6. Marino BS, Lipkin PH, Newburger J.W., Peacock G., Gerdes M, Gaynor JW, Mussatto K.A., Uzark K., Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger D.C., Mahle WT; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012; 126:1143-1172. doi:10.1161/CIR.0b013e318265ee8a.
7. Bannan A, Shen R, Silvestry F.E., Herrmann HC. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv. 2009; 74:1066-1069. doi:10.1002/ccd.22170.
8. Kogon B, Grudziak J, Sahu A., Jokhadar M, McConnell M, Book W., Oster M. Surgery in adults with congenital heart disease: risk factors for morbidity and mortality. Ann Thorac Surg. 2013; 95:1377-1382. doi:10.1016/j.athoracsur.2012.11.076.
9. Niwa K, Nakazawa M, Tateno S., Yoshinaga M, Terai M. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005; 91:795-800. doi:10.1136/hrt.2004.043323.
10. Hoffmann A, Chockalingam P, Balint O.H., Dadashev A., Dimopoulos K, Engel R, Schmid M., Schwerzmann M, Gatzoulis MA, Mulder B, Oechslin E. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010; 96:1223-1226. doi:10.1136/hrt.2010.196147.
11. Chun DS, Schamberger MS, Flaspohler T, Turrentine M.W., Brown JW, Farrell AG, Girod DA. Incidence, outcome, and risk factors for stroke after the Fontan procedure. Am J Cardiol. 2004; 93:117-119.
12. Kutty S, Hazeem AA, Brown K, Danford C.J., Worley SE, Delaney JW, Danford DA, Latson LA Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol. 2012; 109:1348-1352. doi:10.1016/j.amjcard.2011.12.031.
13. Daliento L, Somerville J, Presbitero P., Menti L, Brach-Prever S, Rizzoli G, Stone S. Eisenmenger syndrome: factors relating to deterioration and death. Eur Heart J. 1998; 19:1845-1855.
14. Bernier M, Marelli AJ, Pilote L, Bouchardy J., Bottega N, Martucci G, Therrien J. Atrial arrhythmias in adult patients with right-versus left-sided congenital heart disease anomalies. Am J Cardiol. 2010; 106:547-551. doi:10.1016/j.amjcard.2010.03.068.
15. Andrade SE, Harrold LR, Tjia J, Cutrona S.L., Saczynski JS, Dodd KS, Goldberg RJ, Gurwitz JH A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf. 2012; 21(suppl 1):100-128. doi:10.1002/pds.2312.
16. Mayo N, Danys I, Carlton J., Scott S. Accuracy of hospital discharge coding for stroke. Can J Cardiol. 1993; 9:121D-121D.
17. Hux JE, Ivis F, Flintoft V., Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002; 25:512-516.
18. Selim M. Perioperative stroke. N Engl J Med. 2007; 356:706-713. doi:10.1056/NEJMra062668.
19. Pepi M, Evangelista A, Nihoyannopoulos P., Flachskampf FA, Athanassopoulos G, Colonna P, Habib G., Ringelstein EB, Sicari R, Zamorano JL, Sitges M, Caso P; European Association of Echocardiography. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2010; 11:461-476. doi:10.1093/ejechocard/jeq045.
20. Meissner I, Whisnant JP, Khandheria B.K., Spittell PC, O'Fallon WM, Pascoe RD, Enriquez-Sarano M, Seward J.B., Covalt JL, Sicks JD, Wiebers DO. Prevalence of potential risk factors for stroke assessed by transesoph-ageal echocardiography and carotid ultrasonography: the SPARC study-Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc. 1999; 74:862-869.
21. Putaala J, Metso AJ, Metso T.M., Konkola N., Kraemer Y, Haapaniemi E, Kaste M., Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009; 40:1195-1203. doi:10.1161/STROKEAHA.108.529883.
22. Mayo NE, Nadeau L, Daskalopoulou S.S., Côté R. The evolution of stroke in Quebec: a 15-year perspective. Neurology. 2007; 68:1122-1127. doi:10.1212/01.wnl.0000258664.12423.4c.
23. Peduzzi P, Concato J, Kemper E., Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49:1373-1379.
24. Vandenbroucke J.P., Pearce N. Case-control studies: basic concepts. Int J Epidemiol. 2012; 41:1480-1489. doi:10.1093/ije/dys147.
25. Seeger JD, Williams PL, Walker AM An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf. 2005; 14:465-476. doi:10.1002/pds.1062.
26. Brookhart MA, Schneeweiss S, Rothman K.J., Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006; 163:1149-1156. doi:10.1093/aje/kwj149.
27. Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009; 51:171-184. doi:10.1002/bimj.200810488.
28. Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study-the Practical Incidence Estimators (PIE) macro. Stat Med. 2000; 19:1495-1522.
29. Bélisle P. Sas macro %bicsurv-timedependent, version 4.0.5. http://www.medicine.mcgill.ca/epidemiology/joseph/pbelisle/. Accessed October 12, 2015.
30. Viallefont V, Raftery AE, Richardson S. Variable selection and Bayesian model averaging in case-control studies. Stat Med. 2001; 20:3215-3230.
31. Austin PC. A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality. Multivariate Behav Res. 2011; 46:119-151. doi:10.1080/00273171.2011.540480.
32. Engelfriet P, Boersma E, Oechslin E., Tijssen J, Gatzoulis MA, Thilén U, Kaemmerer H., Moons P, Meijboom F, Popelová J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period-the Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005; 26:2325-2333. doi:10.1093/eurheartj/ehi396.
33. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009; 40:1082-1090. doi:10.1161/STROKEAHA.108.540781.
34. Freudenberger RS, Hellkamp AS, Halperin J.L., Poole J., Anderson J, Johnson G, Mark D.B., Lee KL, Bardy GH; SCD-HeFT Investigators. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2007; 115:2637-2641. doi:10.1161/CIRCULATIONAHA.106.661397.
35. Cuadrado-Godia E., Ois A, Roquer J. Heart failure in acute ischemic stroke. Curr Cardiol Rev. 2010; 6:202-213. doi:10.2174/157340310791658776.
36. Crawford TC, Smith WT 4th, Velazquez EJ, Taylor SM, Jollis JG, Kisslo J. Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. Am J Cardiol. 2004; 93:500-503. doi:10.1016/j.amjcard.2003.10.056.
37. Gibbs CR, Blann AD, Watson R.D., Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation. 2001; 103:1746-1751.
38. Alberts VP, Bos MJ, Koudstaal P, Hofman A., Witteman JC, Stricker B, Breteler M. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010; 25:807-812. doi:10.1007/s10654-010-9520-y.
39. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden R.A., Roger VL. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006; 152:102-109. doi:10.1016/j.ahj.2005.10.018.
40. Gurbel PA, Tantry US Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC Heart Fail. 2014; 2:1-14. doi:10.1016/j.jchf.2013.07.007.
41. Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004; 62:1558-1562.
42. Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol. 2005; 5:5. doi:10.1186/1471-2288-5-5.
43. Volinsky CT, Madigan D, Raftery A.E., Kronmal RA. Bayesian model averaging in proportional hazard models: assessing the risk of a stroke. J R Stat Soc Ser C Appl Stat. 1997; 46:433-448.
44. Jollis JG, Ancukiewicz M, DeLong E.R., Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med. 1993; 119:844-850.
45. Sarrazin MS, Rosenthal GE Finding pure and simple truths with administrative data. JAMA. 2012; 307:1433-1435. doi:10.1001/jama.2012.404.